Recalls & regulatory
FDA approves concentrated Convenia RTU for dogs; launch in 2027
Zoetis says the more concentrated cefovecin injection is meant to cut volumes for large dogs. It and Cytopoint Plus should be available in early 2027.
VetStack NewsSource: dvm360
What was approved
The FDA has approved Convenia RTU for Dogs, a more concentrated formulation of Zoetis' injectable antibiotic cefovecin, according to dvm360. The approval came within weeks of the USDA licensing Cytopoint Plus, Zoetis' longer-acting anti-IL-31 monoclonal antibody.
dvm360 discussed both products with Richard Goldstein, Zoetis' global chief medical officer. He said the company expects to begin taking orders and have both products available in early 2027.